R.E. Aarnoutse
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 7
- Tuberculosis Research and Epidemiology 6
- Virology 5
- HIV Research and Treatment 5
- Co-authors
- David M. Burger (5 shared papers)Martin J. Boeree (4 shared papers)C.P.W.G.M. Verwey-van Wissen (2 shared papers)Stephen H. Gillespie (2 shared papers)Georgette Plemper van Balen (2 shared papers)Rodney Dawson (1 shared paper)Jakko van Ingen (1 shared paper)Andreas H. Diacon (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Clinical Pharmacology (1 paper)Journal of Chromatography B (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
R.E. Aarnoutse
13 papers receiving 537 citations
Peers
Comparison fields: 5 of 86
- Infectious Diseases 375
- Virology 62
- Pharmacology 113
- Pharmacology 55
- Molecular Medicine 31
Countries citing papers authored by R.E. Aarnoutse
This map shows the geographic impact of R.E. Aarnoutse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.E. Aarnoutse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.E. Aarnoutse more than expected).
Fields of papers citing papers by R.E. Aarnoutse
This network shows the impact of papers produced by R.E. Aarnoutse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.E. Aarnoutse. The network helps show where R.E. Aarnoutse may publish in the future.
Co-authors
The 25 scholars most cited alongside R.E. Aarnoutse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 178 | |
| 2 | 2004 | 68 | |
| 3 | 2017 | 56 | |
| 4 | 2016 | 52 | |
| 5 | 2005 | 49 | |
| 6 | 2001 | 32 | |
| 7 | 2007 | 24 | |
| 8 | 2011 | 23 | |
| 9 | 2021 | 23 | |
| 10 | 2015 | 18 | |
| 11 | 2003 | 16 | |
| 12 | 2009 | 13 | |
| 13 | 2005 | 6 |
About R.E. Aarnoutse
R.E. Aarnoutse is a scholar working on Infectious Diseases, Virology, Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 13 papers that have together received 558 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Tuberculosis Research and Epidemiology (6 papers), HIV Research and Treatment (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Biochemical and Molecular Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (375 citations), Virology (62 citations), Pharmacology (113 citations), Pharmacology (55 citations) and Molecular Medicine (31 citations). R.E. Aarnoutse has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include David M. Burger, Martin J. Boeree, C.P.W.G.M. Verwey-van Wissen, Stephen H. Gillespie, Georgette Plemper van Balen, Rodney Dawson, Jakko van Ingen, Andreas H. Diacon, P. R. Donald and Y. A. Hekster. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, The Journal of Clinical Pharmacology, Journal of Chromatography B and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.